Navigation Links
Sunridge Announces Marketing Roll Out of PNT in the Dominican Republic
Date:2/17/2010

FOUNTAIN HILLS, Ariz., Feb. 17 /PRNewswire-FirstCall/ -- Sunridge International (OTC Bulletin Board: SNDZ) announced today that it will be sending a medical team to the Dominican Republic the first week in March to assist S3G with its marketing efforts.

S3G is the exclusive distributor for Pneumatic Trabeculoplasty "PNT" and its disposable product line in the Dominican Republic.  

Having completed a successful seminar with 10 local doctors, S3G received orders for a dozen units and the disposable rings use in the PNT treatment of glaucoma.

"We are going to send in medical personnel to treat patients and teach these initial doctors in the use of the equipment," states G. Richard Smith, CEO of Sunridge (www.sunridgeint.com).  "While there, we will assist with two additional seminars being held in Santiago and Santo Domingo where we expect 50 or more doctors in attendance."

Sam Amegan, S3G's president said, "I want to build off the success of our first seminar.  We have a great deal of interest from the doctors here because glaucoma is such an alarming problem in this country.  It affects over a million people."  Sam goes on to say, "PNT is important because not only is it safe and effective as a treatment, but it is cost effective and affordable to people who might not be able to afford getting treatment otherwise."

"This is going to be a very strong market for our disposable line because of the unusually high incidence of glaucoma in this population.  Once success is proven here, we can expect rapid expansion throughout the rest of the Caribbean," states Mr. Smith.

Glaucoma is the second leading cause of blindness, affecting over 70 million people worldwide.  PNT has been proven (through studies completed over the last 10 yrs) to be a safe and effective treatment with no adverse side effects associated with it, unlike typical forms of glaucoma treatment.

Forward-looking statements in this release are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995.  Investors are cautioned that such forward-looking statements involve risks and uncertainties, including without limitation, continued acceptance of the company's products, increased levels of competition for the company, new products and technological changes, the company's dependence on third-party suppliers, and other risks detailed from time to time in the company's periodic reports filed with the Securities and Exchange Commission.

CONTACT:  Jeff Smith of Sunridge International, +1-480-837-6165, info@sunridgeint.com

SOURCE Sunridge International

RELATED LINKS
http://www.sunridgeint.com/

'/>"/>

SOURCE Sunridge International
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Soligenix Announces Issuance of Hong Kong Patent for its LPM(TM) Oral Drug Delivery Technology
2. Otix Global Announces Results for Fourth Quarter 2009
3. Amicus Therapeutics Announces Fourth Quarter and Full Year 2009 Financial Results and Highlights Product Pipeline Advancements
4. PatientSafe Solutions, Inc. Announces Management Team
5. Sequenom Announces Launch of SensiGene Fetal(XY) (Fetal Sex Determination) Test
6. CalciMedica Announces Issuance of US Patent No. 7,645,588, a Composition Patent Involving STIM1, a Key Component of the CRAC Channel
7. VetCentric Announces Partnership With Pfizer Animal Health
8. Albemarle(R) Announces Custom Manufacturing Alliance with PharmaCore(R)
9. OrbusNeich Announces First Patient Enrolled in Randomized Clinical Trial of Genous(TM) Bio-engineered R stent(TM) in China
10. Health Robotics Announces Successful Transition to new and Distinctively Superior Distribution Channels in North America
11. Amnis Announces Record 2009 Sales
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016  Consumers have taken ... regulators/payers have placed more emphasis on patient outcomes. ... support programs in the pharmaceutical industry have evolved ... Consequently, pharmaceutical companies are focusing on becoming more ... providing products and services that improve health. ...
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... Dublin ... of the " Global Markets for Spectroscopy Equipment" ... This report focuses on the global ... including its applications in various applications. The report deals ... three main industries: pharmaceutical and biotechnology, food and beverage, ...
Breaking Medicine Technology:
(Date:6/26/2016)... North Carolina (PRWEB) , ... June 26, 2016 , ... ... release of a new product that was developed to enhance the health of felines. ... for centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern ... Laude and his M.D from the David Geffen School of Medicine at UCLA. He ... Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
Breaking Medicine News(10 mins):